Liquid pharmaceutical formulations of apixaban
US11833138B1 · kind B1 · utility
0Cited by
3References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 2023 |
| Grant date | Dec 5, 2023 |
| Priority date | — |
| Expiry date | Jan 30, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Certain embodiments of the present disclosure provide liquid pharmaceutical formulations, suitable for oral administration, that contain glycerol and an amount of apixaban in the solution phase of the formulations of from 0.5 mg/ml to 6 mg/ml.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.